Australia markets closed

Harvard Apparatus Regenerative Technology Inc. (HRGN)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
2.68000.0000 (0.00%)
At close: 03:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 37.65M
Enterprise value 37.90M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)228.33
Price/book (mrq)215.14
Enterprise value/revenue 236.86
Enterprise value/EBITDA -7.27

Trading information

Stock price history

Beta (5Y monthly) -1.40
52-week change 3-34.25%
S&P500 52-week change 325.22%
52-week high 36.0000
52-week low 32.1300
50-day moving average 32.4889
200-day moving average 34.0713

Share statistics

Avg vol (3-month) 3980
Avg vol (10-day) 3850
Shares outstanding 514.32M
Implied shares outstanding 614.32M
Float 86.6M
% held by insiders 152.58%
% held by institutions 10.00%
Shares short (29 Sept 2017) 4121.66k
Short ratio (29 Sept 2017) 43.35
Short % of float (29 Sept 2017) 46.77%
Short % of shares outstanding (29 Sept 2017) 46.25%
Shares short (prior month 31 Aug 2017) 4201.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 322 Dec 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,545.61%

Management effectiveness

Return on assets (ttm)-150.42%
Return on equity (ttm)-511.06%

Income statement

Revenue (ttm)160k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -8.1M
Net income avi to common (ttm)-8.08M
Diluted EPS (ttm)-0.5800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)272k
Total cash per share (mrq)0.02
Total debt (mrq)521k
Total debt/equity (mrq)297.71%
Current ratio (mrq)0.28
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-6.89M
Levered free cash flow (ttm)-2.28M